You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Baxter
Mallinckrodt
McKesson
Boehringer Ingelheim

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 8,816,074

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,816,074
Title:2\'-fluoro-6\'-methylene carbocyclic nucleosides and methods of treating viral infections
Abstract: The present invention relates to 2\'-Fluoro-6\'-methylene carbocyclic nucleosides, pharmaceutical compositions containing these nucleosides and their use in the treatment or prophylaxis of a number of viral infections and secondary disease states and conditions thereof, especially including Hepatitis B virus (HBV) and secondary disease states and conditions thereof (cirrhosis and liver cancer), Heptatitis C virus (HCV), Herpes Simplex virus I and II (HSV-1 and HSV-2), cytomegalovirus (CMV), Varicella-Zoster Virus (VZV) and Epstein Barr virus (EBV) and secondary cancers which occur thereof (lymphoma, nasopharyngeal cancer, including drug resistant (especially including lamivudine and/or adefovir resistant) and other mutant forms of these viruses.
Inventor(s): Chu; Chung K. (Stratham, GA), Wang; Jianing (La Jolla, CA)
Assignee: University of Georgia Foundation, Inc. (Athens, GA)
Application Number:13/107,713
Patent Claims:see list of patent claims

Details for Patent 8,816,074

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial University of Georgia Foundation, Inc. (Athens, GA) 2029-11-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial University of Georgia Foundation, Inc. (Athens, GA) 2029-11-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial University of Georgia Foundation, Inc. (Athens, GA) 2029-11-16 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Baxter
Merck
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.